The FAST III trial, published in the New England Journal of Medicine, examines whether angiography-based physiology can reliably guide decisions about coronary artery treatment.
What the NEJM Posted
The New England Journal of Medicine posted to its official account on X, formerly Twitter, announcing the publication of research from the FAST III trial alongside an editorial and a supporting explainer on the science behind the study.
The tweet links to three separate pieces of content: the original trial article examining angiography-based physiology as a tool to guide coronary revascularisation, an editorial titled “Redefining Physiology in the Cardiac Catheterization Laboratory,” and a background explainer on physiological assessment in heart care. All three were published together, suggesting the journal treated this as a package of material warranting simultaneous release.
What Coronary Revascularisation Actually Means
Coronary revascularisation refers to procedures used to restore blood flow through narrowed or blocked coronary arteries — the vessels that supply the heart muscle itself. These include bypass surgery and stenting. The question of *when* to intervene, and which arteries to treat, is one that clinicians have debated for years.
Physiology-guided assessment involves measuring how much a narrowed artery is actually restricting blood flow, rather than relying solely on how it looks on an X-ray image. Angiography-based physiology attempts to calculate that restriction from the angiogram alone, without inserting a separate pressure wire into the artery — a step that adds time, cost, and some procedural complexity.
That distinction matters. If angiography-based measurements prove as reliable as wire-based ones, it could change how catheterisation laboratories operate day to day.
The Editorial Response
The accompanying editorial, “Redefining Physiology in the Cardiac Catheterization Laboratory,” indicates the journal considered the trial findings significant enough to warrant independent expert commentary. Editorials in the NEJM are typically commissioned from clinicians not involved in the original research, offering an external assessment of the evidence.
Meanwhile, the science explainer published alongside both pieces suggests the journal is also addressing a broader readership — including patients, trainees, and non-specialist clinicians — who may be less familiar with the technical background of physiological assessment.
What Remains Unanswered
The tweet does not summarise the trial’s outcomes, and the full findings are behind the journal’s access controls. It is not yet clear from publicly available information whether the FAST III trial found angiography-based physiology to be superior, equivalent, or inferior to existing wire-based methods. The editorial title — using the word “redefining” — may hint at a shift in clinical thinking, but that reading remains speculative without access to the full text.
—
Source: @NEJM
Key Takeaways
- The NEJM has published the FAST III trial, examining angiography-based physiology as a guide for coronary revascularisation decisions
- An accompanying editorial suggests independent expert commentary on the findings has been commissioned
- The full trial outcomes are not publicly summarised in available material; detailed findings require journal access
What This Means for Kent Residents
Cardiology services in Kent are delivered primarily through NHS Kent and Medway, with specialist cardiac catheterisation services available at centres including Maidstone and Tunbridge Wells NHS Trust and Medway NHS Foundation Trust. Research of this kind, once reviewed and adopted into clinical guidelines by bodies such as NICE or the British Cardiovascular Intervention Society, can influence how local cardiologists assess and treat patients with coronary artery disease. Residents who have been told they may need a stenting procedure or are awaiting a cardiology assessment are advised to speak directly with their consultant about what assessment methods are used in their care. For general heart health concerns, NHS 111 is available around the clock, and anyone experiencing chest pain or symptoms of a heart attack should call 999 immediately.
New England Journal of Medicine Publishes Trial Data on Heart Artery Assessment Technique Quiz
5 questions